Achieved Statistical Significance with Up to 48% Slowing of Clinical Progression on UMSARS Rating Scale - MELBOURNE, Australia and SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Alterity ...

By crafting an artificial brain-like environment with microscopic nanopillars, researchers have successfully guided neurons to grow in structured networks. This innovation could revolutionize how scie ...

The Brain Tour, inside dementia is an app designed for iOS and Android phones, that uses augmented reality to transport users inside the brain. Whether you're curious to explore a healthy brain or ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

So I really depend on my medication." Sir Peter Luff, a former defence minister and MP for Mid Worcestershire, explained how ...

People who have Parkinson’s disease aren’t alone. That was something it took Ted Stephens of St. James a while to learn after ...

Robert F. Kennedy Jr. has spasmodic dysphonia, a voice disorder caused by a malfunction in the brain. Here’s what to know.

Following “positive” top-line phase II trial results, neurodegenerative disease house Alterity Therapeutics (ASX:ATH) will ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

A brain implant has allowed a Parkinson's patient to "forget about" his debilitating condition for days at a time. Kevin Hill ...

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

An enzyme that helps clear damaged mitochondria can act as a molecular switch and potentially prevent neurons from dying.